International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 932-941 , 1 July 2010

RapidArc Radiation Therapy: First Year Experience at the University of Alabama at Birmingham

Received 20 May 2009 ,Revised 10 August 2009 ,Accepted 1 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: The University of Alabama at Birmingham has an agreement with Varian Medical Systems for evaluation of the RapidArc™ technology, for which R.A. Popple is the principal evaluator. R.A. Popple also has a research grant with Varian Medical Systems that is unrelated to RapidArc™. R.A. Popple, J.B. Fiveash, and J.A. Bonner are speaking consultants for Varian Medical Systems. J.A. Bonner is a consultant for Bristol-Myers-Squibb, Imclone Systems, and Lilly Corporation.

PII: S0360-3016(09)03046-6

doi: 10.1016/j.ijrobp.2009.09.001

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 932-941 , 1 July 2010

Article Tools

* Image Usage & Resolution